TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 139 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2017. The put-call ratio across all filers is 6.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $2,000 | -33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $3,000 | +50.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | -33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | 0.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | 0.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,000 | -57.1% | 33 | -50.0% | 0.00% | -50.0% |
| Q3 2017 | $7,000 | +75.0% | 66 | +100.0% | 0.00% | +100.0% |
| Q2 2017 | $4,000 | 0.0% | 33 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $4,000 | +33.3% | 33 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $3,000 | -25.0% | 33 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $4,000 | -20.0% | 33 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | 0.0% | 33 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $5,000 | -64.3% | 33 | -64.5% | 0.00% | -62.5% |
| Q4 2015 | $14,000 | +7.7% | 93 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $13,000 | +44.4% | 93 | +55.0% | 0.01% | +33.3% |
| Q2 2015 | $9,000 | -30.8% | 60 | -35.5% | 0.01% | -25.0% |
| Q1 2015 | $13,000 | -7.1% | 93 | 0.0% | 0.01% | -20.0% |
| Q4 2014 | $14,000 | 0.0% | 93 | 0.0% | 0.01% | -9.1% |
| Q3 2014 | $14,000 | -26.3% | 93 | -30.1% | 0.01% | -26.7% |
| Q2 2014 | $19,000 | +26.7% | 133 | 0.0% | 0.02% | +15.4% |
| Q1 2014 | $15,000 | +15.4% | 133 | 0.0% | 0.01% | +18.2% |
| Q4 2013 | $13,000 | +62.5% | 133 | +33.0% | 0.01% | +37.5% |
| Q3 2013 | $8,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |